Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 20:9:113.
doi: 10.1186/1742-4690-9-113.

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome

Affiliations

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome

Diako Ebrahimi et al. Retrovirology. .

Abstract

Background: The human immune proteins APOBEC3G and APOBEC3F (hA3G and hA3F) induce destructive G-to-A changes in the HIV genome, referred to as 'hypermutation'. These two proteins co-express in human cells, co-localize to mRNA processing bodies and might co-package into HIV virions. Therefore they are expected to also co-mutate the HIV genome. Here we investigate the mutational footprints of hA3G and hA3F in a large population of full genome HIV-1 sequences from naturally infected patients to uniquely identify sequences hypermutated by either or both of these proteins. We develop a method of identification based on the representation of hA3G and hA3F target and product motifs that does not require an alignment to a parental/consensus sequence.

Results: Out of nearly 100 hypermutated HIV-1 sequences only one sequence from the HIV-1 outlier group showed clear signatures of co-mutation by both proteins. The remaining sequences were affected by either hA3G or hA3F.

Conclusion: Using a novel method of identification of HIV sequences hypermutated by the hA3G and hA3F enzymes, we report a very low rate of co-mutation of full-length HIV sequences, and discuss the potential mechanisms underlying this.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Hotelling’s T2 statistics of HIV-1 sequences. There are in total 2917 full genome (> 7000 n.t.) HIV-1 sequences including 2829 nominally normal and 88 nominally hypermutated sequences. The hypermutated sequences are from no. 2830-2917 on the horizontal axis. The filled circles are the nominally normal sequences which are significantly different from the normal HIV-1 population at >> 99.9% confidence levels, thus appear to be hypermutated. The filled triangles are the nominally hypermutated sequences that are significantly different from the normal HIV-1 population at < 50% confidence levels, thus appear to be normal.
Figure 2
Figure 2
The plot of DRhA3Gversus DRhA3F of 2917 full genome (>7000 n.t.) HIV-1 sequences. The sequences identified as normal and hypermutated by LANL are shown using black circles and red triangles, respectively. The seven nominally normal sequences with α >> 99.9% (appear outside the 99.9% confidence interval broken line) are shown by filled circles. The two nominally hypermutated sequences with α < 50% are shown by filled triangles. The sequences hypermutated by hA3G appear along the horizontal axis and those affected by hA3F extend along the vertical axis. The sequences co-mutated by hA3G and hA3F locate between these two groups.
Figure 3
Figure 3
The plot of DRhA3G versus DRhA3F of a consensus HIV-1 sequence and 19 sequences hypermutated by either hA3G or hA3F. The consensus sequence is shown using a red triangle. Hypermutated sequences by hA3G or hA3F are shown using open and closed rhombuses, respectively. The 99.9% confidence interval of the subtype B HIV-1 population is shown by an oval. The sequences hypermutated by hA3G appear along the horizontal axis, and those hypermutated by hA3F extend along the vertical axis. There is no co-mutated sequence in this dataset.
Figure 4
Figure 4
The plot of DRhA3G versus DRhA3F for A) normal HIV-1 population and simulated mutations by B) both hA3G & hA3F (GG-to-AG & GA-to-AA), C) hA3G (GG-to-AG), D) hA3F (GA-to-AA) and E) reverse transcriptase (random G-to-A).

References

    1. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004;4:868–877. - PubMed
    1. Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004;2:1278–1285. - PMC - PubMed
    1. Jager S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D. et al.Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature. 2012;481:371–375. - PMC - PubMed
    1. Browne EP, Allers C, Landau NR. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. Virology. 2009;387:313–321. - PMC - PubMed
    1. Holmes RK, Malim MH, Bishop KN. APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci. 2007;32:118–128. - PubMed

Publication types

LinkOut - more resources